IL127331A0 - Peptide-based vaccine for influenza - Google Patents

Peptide-based vaccine for influenza

Info

Publication number
IL127331A0
IL127331A0 IL12733198A IL12733198A IL127331A0 IL 127331 A0 IL127331 A0 IL 127331A0 IL 12733198 A IL12733198 A IL 12733198A IL 12733198 A IL12733198 A IL 12733198A IL 127331 A0 IL127331 A0 IL 127331A0
Authority
IL
Israel
Prior art keywords
epitopes
influenza
epitope
influenza virus
hla molecules
Prior art date
Application number
IL12733198A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL12733198A priority Critical patent/IL127331A0/xx
Publication of IL127331A0 publication Critical patent/IL127331A0/xx
Priority to AU14066/00A priority patent/AU766883B2/en
Priority to NZ511918A priority patent/NZ511918A/en
Priority to BR9915811-6A priority patent/BR9915811A/pt
Priority to EP10003160A priority patent/EP2204187B1/de
Priority to CA2352454A priority patent/CA2352454C/en
Priority to PT10003160T priority patent/PT2204187E/pt
Priority to US09/856,920 priority patent/US6740325B1/en
Priority to JP2000584919A priority patent/JP2002531415A/ja
Priority to ES10003160T priority patent/ES2389611T3/es
Priority to IL14336799A priority patent/IL143367A0/xx
Priority to KR1020017006639A priority patent/KR100703571B1/ko
Priority to EP99972929A priority patent/EP1135159A2/de
Priority to AT10003160T priority patent/ATE556719T1/de
Priority to DK10003160.8T priority patent/DK2204187T3/da
Priority to PCT/IL1999/000640 priority patent/WO2000032228A2/en
Priority to IL143367A priority patent/IL143367A/en
Priority to HK02102105.6A priority patent/HK1040620A1/zh
Priority to US10/846,548 priority patent/US7192595B2/en
Priority to US11/672,429 priority patent/US7514086B2/en
Priority to HK10111907.7A priority patent/HK1145448A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL12733198A 1998-11-30 1998-11-30 Peptide-based vaccine for influenza IL127331A0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
IL12733198A IL127331A0 (en) 1998-11-30 1998-11-30 Peptide-based vaccine for influenza
PCT/IL1999/000640 WO2000032228A2 (en) 1998-11-30 1999-11-28 Peptide-based vaccine for influenza
JP2000584919A JP2002531415A (ja) 1998-11-30 1999-11-28 ペプチドベースのインフルエンザ用ワクチン
IL14336799A IL143367A0 (en) 1998-11-30 1999-11-28 Peptide based vaccine for influenza
BR9915811-6A BR9915811A (pt) 1998-11-30 1999-11-28 Vacina a base de peptìdeo para influenza
EP10003160A EP2204187B1 (de) 1998-11-30 1999-11-28 Impfstoff gegen menschliche Influenza, der vier Peptide aus Influenza enthält
CA2352454A CA2352454C (en) 1998-11-30 1999-11-28 Peptide-based vaccine for influenza
PT10003160T PT2204187E (pt) 1998-11-30 1999-11-28 Vacina contra a gripe humana contendo quatro péptidos de influenza
US09/856,920 US6740325B1 (en) 1998-11-30 1999-11-28 Peptide-based vaccine for influenza
AU14066/00A AU766883B2 (en) 1998-11-30 1999-11-28 Peptide-based vaccine for influenza
ES10003160T ES2389611T3 (es) 1998-11-30 1999-11-28 Vacuna contra la gripe humana que contiene cuatro péptidos de influenza
NZ511918A NZ511918A (en) 1998-11-30 1999-11-28 Flu vaccine comprising four synthetic peptide epitopes
KR1020017006639A KR100703571B1 (ko) 1998-11-30 1999-11-28 인플루엔자에 대한 펩티드-기초 백신
EP99972929A EP1135159A2 (de) 1998-11-30 1999-11-28 Impfstoff auf peptid-basis gegen influenza
AT10003160T ATE556719T1 (de) 1998-11-30 1999-11-28 Impfstoff gegen menschliche influenza, der vier peptide aus influenza enthält
DK10003160.8T DK2204187T3 (da) 1998-11-30 1999-11-28 Human influenzavaccine indeholdende fire influenzapeptider
IL143367A IL143367A (en) 1998-11-30 2001-05-24 Influenza vaccine based on peptides
HK02102105.6A HK1040620A1 (zh) 1998-11-30 2002-03-19 治療流感的肽基疫苗
US10/846,548 US7192595B2 (en) 1998-11-30 2004-05-17 Peptide-based vaccine for influenza
US11/672,429 US7514086B2 (en) 1998-11-30 2007-02-07 Peptide-based vaccine for influenza
HK10111907.7A HK1145448A1 (en) 1998-11-30 2010-12-21 Human flu vaccine containing four influenza peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL12733198A IL127331A0 (en) 1998-11-30 1998-11-30 Peptide-based vaccine for influenza

Publications (1)

Publication Number Publication Date
IL127331A0 true IL127331A0 (en) 1999-09-22

Family

ID=11072200

Family Applications (3)

Application Number Title Priority Date Filing Date
IL12733198A IL127331A0 (en) 1998-11-30 1998-11-30 Peptide-based vaccine for influenza
IL14336799A IL143367A0 (en) 1998-11-30 1999-11-28 Peptide based vaccine for influenza
IL143367A IL143367A (en) 1998-11-30 2001-05-24 Influenza vaccine based on peptides

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL14336799A IL143367A0 (en) 1998-11-30 1999-11-28 Peptide based vaccine for influenza
IL143367A IL143367A (en) 1998-11-30 2001-05-24 Influenza vaccine based on peptides

Country Status (15)

Country Link
US (3) US6740325B1 (de)
EP (2) EP1135159A2 (de)
JP (1) JP2002531415A (de)
KR (1) KR100703571B1 (de)
AT (1) ATE556719T1 (de)
AU (1) AU766883B2 (de)
BR (1) BR9915811A (de)
CA (1) CA2352454C (de)
DK (1) DK2204187T3 (de)
ES (1) ES2389611T3 (de)
HK (2) HK1040620A1 (de)
IL (3) IL127331A0 (de)
NZ (1) NZ511918A (de)
PT (1) PT2204187E (de)
WO (1) WO2000032228A2 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127331A0 (en) * 1998-11-30 1999-09-22 Yeda Res & Dev Peptide-based vaccine for influenza
AU2002223398A1 (en) * 2000-08-10 2002-04-08 Tsinghua University A vaccine for influenza virus and its preparation
FI20031536A0 (fi) * 2003-10-20 2003-10-20 Biotie Therapies Oyj Korkean affiniteetin ligandit influenssavirukselle ja menetelmät niiden valmistamiseen
ES2400456T3 (es) 2003-11-04 2013-04-10 The Administrators Of The Tulane Educational Fund Procedimiento de prevención de la fusión virus célula inhibiendo la función de la región de iniciación de fusión en virus de ARN que tienen proteínas de envoltura fusogénicas de membrana de clase I
GB0716992D0 (en) * 2007-08-31 2007-10-10 Immune Targeting Systems Its L Influenza antigen delivery vectors and constructs
WO2006074303A2 (en) * 2005-01-05 2006-07-13 Philadelphia Health And Education Corporation Delivery vehicles, bioactive substances and viral vaccines
AR052195A1 (es) 2005-01-19 2007-03-07 Vaxinnate Corp Composiciones de patrones moleculares asociados a patogenos en metodos de uso
FI20060200A0 (fi) * 2005-04-20 2006-02-27 Glykos Finland Oy Menetelmä ihmisen influenssaviruksen sialihahappositoumisspesifisyyden analysoimiseksi
KR20080027777A (ko) * 2005-06-01 2008-03-28 배리에이션 바이오테크놀로지스 아이엔씨. 펩티드­기초 인플루엔자 백신 제제
US7871626B2 (en) * 2005-08-04 2011-01-18 St. Jude Children's Research Hospital Modified influenza virus for monitoring and improving vaccine efficiency
US7468187B2 (en) * 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
US20090169576A1 (en) * 2005-10-26 2009-07-02 Roberto Crea Influenza combinatorial antigen vaccine
EP1951862B1 (de) * 2005-11-07 2013-07-24 MicroVAX, LLC Cd40-ligand-fusionsproteinimpfstoff
AU2006322907B2 (en) * 2005-12-06 2012-08-02 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Improved influenza vaccine
KR20080089663A (ko) * 2006-01-27 2008-10-07 노바티스 백신즈 앤드 다이아그노스틱스 게엠베하 운트 콤파니 카게 적혈구응집소 및 기질 단백질을 함유한 인플루엔자 백신
GB0613977D0 (en) 2006-02-07 2006-08-23 Peptcell Ltd Peptide sequences and compositions
CA2638760A1 (en) 2006-03-07 2007-09-13 Vaxinnate Corporation Compositions that include hemagglutinin, methods of making and methods of use thereof
US20080208486A1 (en) * 2006-03-23 2008-08-28 Jari Natunen Integrated System, Device and Use Thereof
US8222204B2 (en) 2006-05-03 2012-07-17 The Administrators of the Tulane Educational Fund and Autoimmune Technologies, LLC Influenza inhibiting compositions and methods
US20110129438A1 (en) * 2006-06-28 2011-06-02 James Robert Swartz Immunogenic protein constructs
FI20060946A0 (fi) * 2006-10-26 2006-10-26 Glykos Finland Oy Influenssaviruksen nukleiinihappoja ja peptidejä
CA2680600A1 (en) * 2007-03-12 2008-09-18 Antigen Express, Inc. Li-rnai involved li suppression in cancer immunotherapy
CA2695399C (en) * 2007-08-02 2017-10-17 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope influenza vaccines
EP2280991B1 (de) 2008-04-18 2016-06-22 VaxInnate Corporation Flagellin deletionsmutanten und deren verwendung
EP2278997B1 (de) 2008-04-21 2016-08-10 Nanobio Corporation Nanoemulsions-grippeimpfstoff
US20090297552A1 (en) * 2008-04-25 2009-12-03 Aderem Alan A Flagellin polypeptide vaccines
US8486619B2 (en) 2008-05-02 2013-07-16 University Of Rochester Arrayed imaging reflectometry (air) sensor chip comprising influenza hemagglutinin (HA) polypeptides suitable for the detection of antiviral immune responses
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof
BR112012000826B1 (pt) 2009-07-06 2022-07-26 Variation Biotechnologies Inc Método para a preparação de vesículas
WO2011005772A1 (en) 2009-07-06 2011-01-13 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
JP6119030B2 (ja) 2010-07-06 2017-04-26 ヴァリエーション バイオテクノロジーズ インコーポレイテッド インフルエンザを治療するための組成物及び方法
EP2663327A4 (de) 2011-01-13 2015-12-02 Variation Biotechnologies Inc Zusammensetzungen und verfahren zur behandlung von virusinfektionen
CN103533923A (zh) 2011-01-13 2014-01-22 变异生物技术公司 囊泡及由其产生之制剂的制备方法
WO2012114323A1 (en) 2011-02-22 2012-08-30 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
US9492525B2 (en) 2011-07-06 2016-11-15 Nanobio Corporation Human respiratory syncytial virus vaccine
WO2013028738A1 (en) 2011-08-22 2013-02-28 Nanobio Corporation Herpes simplex virus nanoemulsion vaccine
CA2890084C (en) 2011-11-18 2021-05-04 Maura Ellen Campbell Synthetic derivatives of mpl and uses thereof
WO2013104995A2 (en) 2012-01-12 2013-07-18 Variation Biotechnologies, Inc. Compositions and methods for treating viral infections
EP2806894A4 (de) 2012-01-27 2015-11-04 Variation Biotechnologies Inc Verfahren und zusammensetzungen für therapeutika
US8932598B2 (en) 2012-08-28 2015-01-13 Vaxinnate Corporation Fusion proteins and methods of use
JP6440360B2 (ja) 2013-02-05 2018-12-19 日東電工株式会社 経皮投与用ワクチン組成物
JP2014169278A (ja) 2013-02-05 2014-09-18 Nitto Denko Corp 経皮投与用ワクチン組成物
US10206985B2 (en) 2013-02-05 2019-02-19 Nitto Denko Corporation WT1 peptide cancer vaccine composition for mucosal administration
JP6512568B2 (ja) 2013-02-05 2019-05-15 日東電工株式会社 経皮投与用ｗｔ１ペプチド癌ワクチン組成物
CA2840978A1 (en) * 2013-02-05 2014-08-05 Nitto Denko Corporation Vaccine composition for mucosal administration
KR20140100420A (ko) 2013-02-05 2014-08-14 닛토덴코 가부시키가이샤 경피 또는 점막 투여용 백신 조성물
US10071051B2 (en) 2013-02-05 2018-09-11 Nitto Denko Corporation WT1 peptide cancer vaccine composition for transdermal administration
KR102050931B1 (ko) 2013-02-05 2019-12-02 닛토덴코 가부시키가이샤 경피 투여용 ｗｔ1 펩티드 암 백신 테이프제
CA2840959A1 (en) 2013-02-05 2014-08-05 Nitto Denko Corporation Vaccine composition
RU2014102941A (ru) 2013-02-05 2015-08-10 Нитто Денко Корпорейшн Вакцинная композиция для введения через слизистую оболочку
RU2531235C2 (ru) 2013-02-15 2014-10-20 Общество с ограниченной ответственностью "Универсальные БиоСистемы" (ООО "УБС") Поливалентная вакцина против гриппа на основе гибридного белка
CN103901202B (zh) * 2014-04-04 2015-08-12 中国人民解放军成都军区疾病预防控制中心 基于共有表位甲型流感病毒抗体通用型竞争性elisa检测方法
JP6980360B2 (ja) 2014-09-03 2021-12-15 日東電工株式会社 ビスホスホネート剤を含む液性免疫用ワクチン医薬組成物
US10925936B2 (en) 2014-09-03 2021-02-23 Nitto Denko Corporation Vaccine pharmaceutical composition for cell-mediated immunity containing bisphosphonates
CN107847602A (zh) 2015-08-06 2018-03-27 日东电工株式会社 免疫诱导促进组合物和疫苗药物组合物
CA3048448A1 (en) 2016-12-28 2018-07-05 Invvax, Inc. Influenza vaccines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61904A (en) 1981-01-13 1985-07-31 Yeda Res & Dev Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
IL101639A0 (en) * 1992-04-17 1992-12-30 Yeda Res & Dev Recombinant influenza vaccines
WO1997044667A2 (fr) * 1996-05-21 1997-11-27 Institut Pasteur Methodes d'utilisation de complexes peptide/complexe majeur d'histocompatibilite pour obtenir ou purifier des cellules t antigene-specifiques et pour stimuler des cellules t
IL127331A0 (en) * 1998-11-30 1999-09-22 Yeda Res & Dev Peptide-based vaccine for influenza

Also Published As

Publication number Publication date
CA2352454C (en) 2013-02-05
NZ511918A (en) 2003-08-29
IL143367A0 (en) 2002-04-21
EP1135159A2 (de) 2001-09-26
KR100703571B1 (ko) 2007-04-05
AU766883B2 (en) 2003-10-23
WO2000032228A3 (en) 2000-10-05
AU1406600A (en) 2000-06-19
US7192595B2 (en) 2007-03-20
JP2002531415A (ja) 2002-09-24
EP2204187A1 (de) 2010-07-07
ATE556719T1 (de) 2012-05-15
HK1145448A1 (en) 2011-04-21
US7514086B2 (en) 2009-04-07
US6740325B1 (en) 2004-05-25
US20070122424A1 (en) 2007-05-31
EP2204187B1 (de) 2012-05-09
IL143367A (en) 2006-09-05
BR9915811A (pt) 2001-08-21
KR20010089512A (ko) 2001-10-06
WO2000032228A2 (en) 2000-06-08
CA2352454A1 (en) 2000-06-08
PT2204187E (pt) 2012-08-10
US20050002954A1 (en) 2005-01-06
HK1040620A1 (zh) 2002-06-21
ES2389611T3 (es) 2012-10-29
DK2204187T3 (da) 2012-08-20

Similar Documents

Publication Publication Date Title
IL127331A0 (en) Peptide-based vaccine for influenza
JP2002531415A5 (de)
Liu et al. High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity
Schild et al. Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide.
DK1036058T3 (da) Adamantanderivater
CA2164818A1 (en) Tandem synthetic hiv-1 peptides
RS51157B (sr) Baff receptor (bcma), imunoregulatorni agens
ATE277633T1 (de) Präparate und verfahren zum auslösen von ctl- immunität
AR008765A1 (es) Un peptido o un derivado, analogo o variante, funcional del mismo, un peptido recombinante o sintetico del mismo, una secuencia nucleotidica y vectorque la contiene, una celula huesped transformada, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un compuesto del
ES2619332T3 (es) Fosfatasa alcalina dirigida al hueso, kits y métodos de uso de la misma
EP0259149A3 (en) The use of rotavirus nucleocapsid protein vp6 in vaccine compositions
ES2121830T3 (es) Procedimiento para la preparacion a escala industrial de un concentrado de factor de willebrand humano normalizado de pureza muy elevada apropiado para uso terapeutico.
RS51602B (sr) April receptor (bcma) i njegova upotreba
BR0009580A (pt) Composição, processos para preparar vìrus da influenza, para preparar um veìculo de liberação de genes, para preparar vìrus da influenza defeituosos de replicação infecciosa, para imunizar um paciente contra um patógeno, para preparar vìrus infeccioso, e para preparar vìrus, vìrus, célula, vetor, célula hospedeira, e, uso do vìrus
ATE35152T1 (de) Plasmide und modifizierte staemme von vibrio cholerae, ihre herstellung und davon abgeleitete vakzine.
NO880494L (no) Syntetiske nonapeptid- og decapeptidanaloger av lhrh som er anvendelige som lhrh-antagonister.
BR9307029A (pt) Mecanismo de empacotamento de suporte de artigo do tipo clipe
ATE404583T1 (de) Funktionelle antagonisten von hedgehog-aktivität
BR9912176A (pt) Epìtopos de célula auxiliar t artificial como estimuladores imunes para imunógenos de peptìdeo sintéticos incluindo peptìdeos de lhrh imunogênicos
AU4622693A (en) Potentiation of immunogenic response
ATE326237T1 (de) Miscmicellen aus lipopeptiden für induzierung einer immunantwort
ATE216246T1 (de) Pharmazeutisches praeparat auf der basis eines diclofenac-salzes und der verbindung thiocolchicosid
MX9702666A (es) Nuevos peptidos con efectos inmunoreguladores.
ES2171086T3 (es) Uso de proteinas hmg para la preparacion de medicamentos con actividad citotoxica.
DE69527708D1 (de) Synthetischer impfstoff zum schutz gegen infektionen mit dem menschlichen immunschwächevirus